Dr. Reddy's Laboratories Files Form 6-K
Ticker: RDY · Form: 6-K · Filed: Sep 3, 2024 · CIK: 1135951
Sentiment: neutral
Topics: reporting, foreign-issuer, compliance
TL;DR
DRL filed a 6-K, standard reporting for foreign issuers.
AI Summary
Dr. Reddy's Laboratories Ltd. filed a Form 6-K on August 31, 2024, reporting as a foreign private issuer. The filing is in accordance with Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934. The company is based in Hyderabad, India, and its fiscal year ends on March 31.
Why It Matters
This filing indicates ongoing reporting compliance for Dr. Reddy's Laboratories, a significant player in the pharmaceutical industry, ensuring transparency for investors.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer and does not contain new material financial information or strategic changes.
Key Players & Entities
- DR REDDYS LABORATORIES LTD (company) — Registrant
- 0001575872-24-000967 (filing_id) — Accession Number
- 20240831 (date) — Period of Report
- 20240903 (date) — Filing Date
- Hyderabad, India (location) — Company Headquarters
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to furnish information which the issuer makes or is required to make public in its home country.
When was this Form 6-K filed?
This Form 6-K was filed on September 3, 2024.
What is the reporting period for this filing?
The conformed period of report for this filing is August 31, 2024.
Where is Dr. Reddy's Laboratories Ltd. headquartered?
Dr. Reddy's Laboratories Ltd. is headquartered in Hyderabad, India.
Does Dr. Reddy's Laboratories Ltd. file annual reports under Form 20-F or 40-F?
Dr. Reddy's Laboratories Ltd. indicates that it files annual reports under cover of Form 20-F.
Filing Stats: 402 words · 2 min read · ~1 pages · Grade level 16.7 · Accepted 2024-09-03 06:06:49
Filing Documents
- drr0666_6k.htm (6-K) — 13KB
- drr0666_ex99-1.htm (EX-99.1) — 12KB
- drr0666_ex99-1img01.jpg (GRAPHIC) — 2KB
- drr0666_ex99-1img02.jpg (GRAPHIC) — 50KB
- drr0666_ex99-1img03.jpg (GRAPHIC) — 63KB
- 0001575872-24-000967.txt ( ) — 185KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. DR. REDDY’S LABORATORIES LIMITED (Registrant) Date: August 31, 2024 By: /s/ K Randhir Singh Name: K Randhir Singh Title: Company Secretary 3